LMS CAPITAL PLC

Director's Dealing • Apr 30, 2020

National Storage Mechanism | Additional information

RNS Number : 5218L

LMS Capital PLC

30 April 2020

Director/PDMR Shareholding Announcement

LMS Capital plc

(the "Company")

Director / PDMR Shareholding

30 April 2020

The Company was notified on 30 April 2020 that Graham Stedman, Non-Executive Director of the Company, purchased 20,000 ordinary shares of 10 pence each ("Ordinary Shares") at a price of 35.824 pence per Ordinary Share.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transactions described above.  

1	Details of the person discharging managerial responsibilities / person closely associated
a	Name	Graham Stedman
2	Reason for the notification
a	Position / status	Director of LMS Capital plc
b	Initial notification / Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a	Name	LMS Capital plc
b	LEI	2138004UJ1TW8UCELX08
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a	Description of the financial instrument, type of instrument	10p Ordinary shares in LMS Capital plc
	Identification code	GB00B12MHD28
b	Nature of the transaction	Purchase
c	Price(s) and volume(s)	Price(s)	Volume(s)
£0.35824	20,000
d	Aggregated information - Aggregated volume	20,000
	- Price - Total	£0.35824 £7,164.80
e	Date of the transaction	30 April 2020
f	Place of the transaction	London Stock Exchange (XLON)

For further information, please contact:

LMS Capital plc

Lisa O'Sullivan, IQ-EQ Corporate Services (UK) Ltd                                             +353 86 130 4475

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHURSARRKUSOAR